NCT00187031View on ClinicalTrials.gov

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

October 31, 2007

Conditions
Wilms Tumor
Interventions
DRUG

Topotecan, Filgrastim (G-CSF), Pegfilgrastim

See detailed description section for additional details.

Trial Locations (7)

30301

Children's Healthcare, Atlanta

38105

St. Jude Children's Research Hospital, Memphis

77030

Baylor College of Medicine, Houston

02115-6084

Dana Farber, Boston

T2N 4N2

Tom Baker Cancer Center, Calgary

T2W 3N2

Alberta Children's Hospital, Calgary

M5G 1X8

Hospital of Sick Children, Toronto

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

St. Jude Children's Research Hospital

OTHER